Web Results

Drotrecogin alfa

en.wikipedia.org/wiki/Drotrecogin_alfa

Drotrecogin alfa (activated) (Xigris, marketed by Eli Lilly and Company) is a recombinant form of human activated protein C that has anti-thrombotic, ...

Drotrecogin alfa (activated): the first FDA-approved treatment for ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC1276518/

Drotrecogin alfa (activated) (Xigris, Eli Lilly and Company, Indianapolis, Ind) is a recombinant form of human activated protein C. It was approved by the Food ...

Xigris (Drotrecogin alfa) Drug Information: Indications, Dosage and ...

www.rxlist.com/xigris-drug/indications-dosage.htm

Learn about indications, dosage and how it is supplied for the drug Xigris ( Drotrecogin alfa).

Xigris (Drotrecogin alfa) Drug Information: Description, User ... - RxList

www.rxlist.com/xigris-drug.htm

Sep 1, 2009 ... Xigris (drotrecogin alfa (activated)) is a recombinant form of human activated protein C. An established human cell line possessing the ...

Xigris (drotrecogin alfa) Drug Side Effects, Interactions, and ...

www.emedicinehealth.com/drug-drotrecogin_alfa/article_em.htm

Drug information on Xigris (drotrecogin alfa), includes drug pictures, side effects, drug interactions, directions for use, symptoms of overdose, and what to avoid.

Sepsis Drug Xigris Pulled From Worldwide Market - Medscape

www.medscape.com/viewarticle/752169

Oct 25, 2011 ... October 25, 2011 — Eli Lilly is withdrawing activated drotrecogin alfa (Xigris), a drug intended to treat severe sepsis in high-risk patients, from ...

Drug Safety and Availability > FDA Drug Safety Communication ...

www.fda.gov/Drugs/DrugSafety/ucm277114.htm

FDA Drug Safety Communication: Voluntary market withdrawal of Xigris [ drotrecogin alfa (activated)] due to failure to show a survival benefit. Share · Tweet ...

Safety Alerts for Human Medical Products > Xigris [drotrecogin alfa ...

www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm277143.htm

Oct 25, 2011 ... Xigris [drotrecogin alfa (activated)]: Market Withdrawal - Failure to Show Survival Benefit. Share · Tweet · Linkedin · Pin it; More sharing options.

Drotrecogin Alfa (Activated) in Adults with Septic Shock — NEJM

www.nejm.org/doi/full/10.1056/NEJMoa1202290

May 31, 2012 ... There have been conflicting reports on the efficacy of recombinant human activated protein C, or drotrecogin alfa (activated) (DrotAA), for the ...

Xigris (drotrecogin alfa): withdrawal & recall | Therapeutic Goods ...

www.tga.gov.au/alert/xigris-drotrecogin-alfa-withdrawal-recall

Sep 23, 2015 ... The Therapeutic Goods Administration (TGA) advises that Xigris (drotrecogin alfa ) is currently being withdrawn from the worldwide market and ...

Popular Q&A
Q: What is drotrecogin alfa?
A: Drotrecogin alfa is a form of human protein (Protein C). Drotrecogin alfa is used to treat sepsis in patients who have a high risk of death due to multi-system ... Read More »
Source: www.drugs.com
Q: What is xigris (drotrecogin alfa)?
A: Drotrecogin alfa is a form of human protein (Protein C). Drotrecogin alfa is used to treat sepsis in patients who have a high risk of death due to multi-system ... Read More »
Source: www.drugs.com
Q: What is drotrecogin alfa (Xigris)?
A: Drotrecogin alfa is a form of human protein (Protein C). Drotrecogin alfa is used to treat sepsis in patients who have a high risk of death due to multi-system ... Read More »
Source: www.rxlist.com
Q: How is drotrecogin alfa given?
A: Drotrecogin alfa is given as an injection through a needle placed into a vein. You will most likely receive this injection in a hospital setting. Drotrecogin al... Read More »
Source: www.health.com
Helpful Resources

Drotrecogin alfa: Indications, Side Effects, Warnings - Drugs.com

www.drugs.com

Easy to read patient leaflet for drotrecogin alfa. Includes indications, proper use, special instructions, precautions, and possible side effects.